Sisomicin is a potent aminoglycoside antibiotic derived from the fermentation broth of Micromonospora species, primarily investigated for its efficacy in treating pyoderma and various bacterial infections.… Read more








Sisomicin is a potent aminoglycoside antibiotic derived from the fermentation broth of Micromonospora species, primarily investigated for its efficacy in treating pyoderma and various bacterial infections. This category provides essential reference standards for sisomicin, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for impurity profiling, method validation, and rigorous quality control protocols to ensure drug purity and compliance with regulatory standards. By employing specific impurity markers, such as N-nitroso derivatives and related aminoglycoside substances, researchers can accurately identify and quantify potential degradation products and synthesis by-products during stability testing and analytical method development. These reliable standards support precise chromatographic analysis and the overall verification of antibiotic consistency in pharmaceutical research.